Janney Montgomery Scott LLC increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 98.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 114,696 shares of the company's stock after purchasing an additional 56,921 shares during the quarter. Janney Montgomery Scott LLC's holdings in GE HealthCare Technologies were worth $8,496,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $25,000. Bogart Wealth LLC lifted its position in GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after acquiring an additional 247 shares during the period. Stonebridge Financial Group LLC boosted its stake in GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after acquiring an additional 222 shares in the last quarter. Olde Wealth Management LLC purchased a new stake in GE HealthCare Technologies in the first quarter worth about $35,000. Finally, Zions Bancorporation National Association UT bought a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $42,000. 82.06% of the stock is owned by hedge funds and other institutional investors.
GE HealthCare Technologies Stock Down 0.3%
Shares of GEHC stock opened at $76.56 on Monday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company's fifty day moving average price is $74.25 and its 200-day moving average price is $72.48. The company has a market capitalization of $34.95 billion, a price-to-earnings ratio of 15.69, a PEG ratio of 2.93 and a beta of 1.13.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the prior year, the firm posted $1.00 EPS. GE HealthCare Technologies's quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies's dividend payout ratio (DPR) is 2.87%.
Wall Street Analyst Weigh In
GEHC has been the topic of a number of analyst reports. Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a research report on Thursday, September 18th. Zacks Research downgraded GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a report on Monday, September 29th. Citigroup increased their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Weiss Ratings restated a "hold (c)" rating on shares of GE HealthCare Technologies in a report on Saturday, September 27th. Finally, Wall Street Zen cut shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, September 20th. Seven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $86.89.
Read Our Latest Report on GEHC
GE HealthCare Technologies Company Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
